Relmada Therapeutics, Inc. (RLMD)

3.845 -0.22 (-5.30%) USD  |  NASDAQ  |  Jan 14, 16:00
3.845 0.00 (0.00%) After-Hours: 18:53
More

Relmada Therapeutics Non-Current Deferred Liabilities (Quarterly)

Non-Current Deferred Liabilities (Quarterly) Chart

View Non-Current Deferred Liabilities (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Liabilities (Quarterly) Benchmarks

View Non-Current Deferred Liabilities (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Invivyd, Inc. --
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. --
NovaBay Pharmaceuticals, Inc. --